Easton Pharmaceuticals Inc.

July 19, 2011 06:00 ET

Easton Pharmaceuticals Announces Dr. Asa Hershoff, Prominent Herbal and Homeopathic Medicine Expert and Author, as a Senior Consultant to Research and Development

Easton Boosts R&D Capabilities With Key Consultant and Team Addition

TORONTO, ONTARIO--(Marketwire - July 19, 2011) - Easton Pharmaceuticals (OTC:EAPH), a specialty pharmaceutical company that designs, develops, and markets a premium array of topically-delivered therapeutic healthcare products announced today that Dr. Asa Hershoff has agreed to join the company as a senior consultant of Research and Development. Dr. Hershoff will add his expertise in formulating natural medicines to assist the development of Easton Pharma's future product pipeline.

Dr. Hershoff's broad experience in the formulation of medicinal compounds includes developing more than 250 nutritional supplements and herbal medicines for companies like Nu-Life (Canada's largest supplement manufacturer), which are currently sold in most pharmacies in Canada and the United States. He has authored three books on homeopathy for musculoskeletal healing, and has consulted for many of the top nutritional supplement and homeopathic manufacturers in North America.

"We are extremely pleased to have someone of Dr. Hershoff's stature and experience join our consultant team and assist in our R&D efforts," says John Easton, Easton Pharmaceuticals' CEO and Chairman of the Board. "Dr. Hershoff will be a key member of our consultant team as Easton Pharmaceuticals develops its internal pipeline of candidate products towards commercialization."

Dr. Hershoff is a recognized Naturopathic Physician and Chiropractor with over 35 years of specialization in herbal and homeopathic medicine. Dr. Hershoff was chief medical consultant and lecturer for Boericke & Tafel (America's oldest homeopathic pharmacy), and a medical consultant and lecturer for Dolisos, BHI/Heel, Seroyal Canada, NaturPharm, Hobon, Natraceuticals, and Energetique. A Diplomat of the Homeopathic Academy of Naturopathic Physicians (DHANP) in 1998, Dr. Hershoff is a graduate of the Canadian Memorial Chiropractic College and the Canadian College of Naturopathic Medicine and has offices in Los Angeles and New York City and Toronto Ontario Canada.

About Easton Pharmaceuticals

Toronto-based Easton Pharmaceuticals is a specialty pharmaceutical company that designs, develops, and markets a premium array of topically-delivered therapeutic healthcare products, focused on skin and circulatory conditions that impact a large and expanding number of consumers including health issues related to male and female sexual dysfunction, scar and stretch marks, cellulite and varicose veins, the world market for these conditions is in excess of $10 billion.

The company's proprietary gel formulation is an innovative and unique transdermal delivery system. Easton Pharmaceuticals' flagship product, VIORRA, is an over-the-counter aid for the treatment to restore and improve vaginal moisture and elasticity which has a very positive effect on women's sexual desire and arousal, FSAD (Female Sexual Arousal Disorder) the world market for these female conditions are in excess of $2 billion. VIORRA is a topical, daily-use product classified by the FDA as containing Generally Recognized as Safe ingredients.

For More Information Visit http://www.eastonpharma.com.

Safe Harbor

This news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when used in the preceding of discussion, the words "pleased," "plan," "confident that," "believe," "expect," or "intent to" and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company's products and technologies, competitive factors, the ability to successfully complete additional or adequate financing and other risks and uncertainties as stated in the company's financial reports and filings.

Copyright ©2011 Easton Pharmaceuticals Inc. All rights reserved. Easton Pharmaceuticals, Easton Pharma and the Easton Pharmaceuticals logo, and all other Easton Pharmaceuticals company, product, and services names and slogans are trademarks or registered trademarks of Easton Pharmaceuticals Inc.

Contact Information